Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Neurofibromatosis Type I and Plexiform Neurofibromas.

Document Type

Journal Article

Publication Date

3-1-2013

Journal

Pediatric blood & cancer

Volume

60

Issue

3

Inclusive Pages

396–401

DOI

10.1002/pbc.24281

Keywords

Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Male; Maximum Tolerated Dose; Neurofibroma, Plexiform; Neurofibromatosis 1; Niacinamide; Phenylurea Compounds; Sorafenib

Peer Reviewed

1

This document is currently not available here.

Share

COinS